151 related articles for article (PubMed ID: 15164121)
1. Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer.
Akahira JI; Aoki M; Suzuki T; Moriya T; Niikura H; Ito K; Inoue S; Okamura K; Sasano H; Yaegashi N
Br J Cancer; 2004 Jun; 90(11):2197-202. PubMed ID: 15164121
[TBL] [Abstract][Full Text] [Related]
2. EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions.
Suzuki T; Inoue S; Kawabata W; Akahira J; Moriya T; Tsuchiya F; Ogawa S; Muramatsu M; Sasano H
Br J Cancer; 2001 Nov; 85(11):1731-7. PubMed ID: 11742495
[TBL] [Abstract][Full Text] [Related]
3. EBAG9/RCAS1 expression in hepatocellular carcinoma: correlation with tumour dedifferentiation and proliferation.
Aoki T; Inoue S; Imamura H; Fukushima J; Takahashi S; Urano T; Hasegawa K; Ogushi T; Ouchi Y; Makuuchi M
Eur J Cancer; 2003 Jul; 39(11):1552-61. PubMed ID: 12855262
[TBL] [Abstract][Full Text] [Related]
4. EBAG9/RCAS1 expression and its prognostic significance in prostatic cancer.
Takahashi S; Urano T; Tsuchiya F; Fujimura T; Kitamura T; Ouchi Y; Muramatsu M; Inoue S
Int J Cancer; 2003 Sep; 106(3):310-5. PubMed ID: 12845666
[TBL] [Abstract][Full Text] [Related]
5. Expression of estrogen-responsive finger protein (Efp) is associated with advanced disease in human epithelial ovarian cancer.
Sakuma M; Akahira J; Suzuki T; Inoue S; Ito K; Moriya T; Sasano H; Okamura K; Yaegashi N
Gynecol Oncol; 2005 Dec; 99(3):664-70. PubMed ID: 16140366
[TBL] [Abstract][Full Text] [Related]
6. A highly polymorphic CA repeat marker at the EBAG9/RCAS1 locus on 8q23 that detected frequent multiplication in breast cancer.
Tsuneizumi M; Nagai H; Harada H; Kazui T; Emi M
Ann Hum Biol; 2002; 29(4):457-60. PubMed ID: 12160478
[TBL] [Abstract][Full Text] [Related]
7. Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker.
Reimer TA; Anagnostopoulos I; Erdmann B; Lehmann I; Stein H; Daniel P; Dörken B; Rehm A
BMC Cancer; 2005 May; 5():47. PubMed ID: 15904507
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and characterization of mouse EBAG9, homolog of a human cancer associated surface antigen: expression and regulation by estrogen.
Tsuchiya F; Ikeda K; Tsutsumi O; Hiroi H; Momoeda M; Taketani Y; Muramatsu M; Inoue S
Biochem Biophys Res Commun; 2001 Jun; 284(1):2-10. PubMed ID: 11374862
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor-binding fragment-associated gene 9 expression and its clinical significance in human testicular cancer.
Fujimura T; Takahashi S; Urano T; Xiaoqiang L; Ogushi T; Muramatsu M; Ouchi Y; Kitamura T; Homma Y; Inoue S
Int J Urol; 2009 Mar; 16(3):329-32. PubMed ID: 19207611
[TBL] [Abstract][Full Text] [Related]
10. Overrepresentation of the EBAG9 gene at 8q23 associated with early-stage breast cancers.
Tsuneizumi M; Emi M; Nagai H; Harada H; Sakamoto G; Kasumi F; Inoue S; Kazui T; Nakamura Y
Clin Cancer Res; 2001 Nov; 7(11):3526-32. PubMed ID: 11705872
[TBL] [Abstract][Full Text] [Related]
11. Association of positive EBAG9 immunoreactivity with unfavorable prognosis in breast cancer patients treated with tamoxifen.
Ijichi N; Shigekawa T; Ikeda K; Miyazaki T; Horie-Inoue K; Shimizu C; Saji S; Aogi K; Tsuda H; Osaki A; Saeki T; Inoue S
Clin Breast Cancer; 2013 Dec; 13(6):465-70. PubMed ID: 24119785
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinoma.
Ogushi T; Takahashi S; Takeuchi T; Urano T; Horie-Inoue K; Kumagai J; Kitamura T; Ouchi Y; Muramatsu M; Inoue S
Cancer Res; 2005 May; 65(9):3700-6. PubMed ID: 15867365
[TBL] [Abstract][Full Text] [Related]
13. Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.
Suzuki T; Miki Y; Moriya T; Shimada N; Ishida T; Hirakawa H; Ohuchi N; Sasano H
Cancer Res; 2004 Jul; 64(13):4670-6. PubMed ID: 15231680
[TBL] [Abstract][Full Text] [Related]
14. [Expression of receptor-binding cancer antigen expressed on SiSo cells in endometrial carcinoma and the correlation thereof with the expression of estrogen receptor subtypes].
Zhou XH; Xu ST; Song WY; Teng XD
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1900-3. PubMed ID: 17923013
[TBL] [Abstract][Full Text] [Related]
15. Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines.
Zhang S; Zhou X; Yu H; Yu Y
BMC Cancer; 2010 Apr; 10():163. PubMed ID: 20423514
[TBL] [Abstract][Full Text] [Related]
16. The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer.
Hu Z; Zhu L; Tan M; Cai M; Deng L; Yu G; Liu D; Liu J; Lin B
Biochimie; 2015 Feb; 109():42-8. PubMed ID: 25500588
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation.
Akahira J; Sugihashi Y; Suzuki T; Ito K; Niikura H; Moriya T; Nitta M; Okamura H; Inoue S; Sasano H; Okamura K; Yaegashi N
Clin Cancer Res; 2004 Apr; 10(8):2687-93. PubMed ID: 15102672
[TBL] [Abstract][Full Text] [Related]
18. RCAS1 is associated with ductal breast cancer progression.
Rousseau J; Têtu B; Caron D; Malenfant P; Cattaruzzi P; Audette M; Doillon C; Tremblay JP; Guérette B
Biochem Biophys Res Commun; 2002 May; 293(5):1544-9. PubMed ID: 12054692
[TBL] [Abstract][Full Text] [Related]
19. Promoter analysis and chromosomal mapping of human EBAG9 gene.
Ikeda K; Sato M; Tsutsumi O; Tsuchiya F; Tsuneizumi M; Emi M; Imoto I; Inazawa J; Muramatsu M; Inoue S
Biochem Biophys Res Commun; 2000 Jul; 273(2):654-60. PubMed ID: 10873660
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic and membranous receptor-binding cancer antigens expressed on SiSo cells (RCAS1) immunoreactivity in epithelial ovarian cancer cells represent differing biological function of RCAS1.
Szubert S; Jozwicki W; Wicherek L; Koper K
Folia Histochem Cytobiol; 2019; 57(3):116-126. PubMed ID: 31388982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
